GAPDHP19

Across TCGA pan-cancer cohorts, GAPDHP19 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated GAPDHP19 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher GAPDHP19 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated GAPDHP19 expression acts as an unfavorable survival marker, although some lineages such as COAD and READ show a favorable association.

COAD, SKCM, and ACC are the cancer types where GAPDHP19 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	All	0.865	0.472	.016	48	view →
SKCM	DFS	Tertile	All	0.082	0.245	.010	21	view →
ACC	DFS	Tertile	All	0.103	0.645	.001	21	view →
PAAD	DFS	Tertile	All	0.060	0.468	<.001	18	view →
READ	DFS	Tertile	All	1.000	0.467	.019	18	view →
SARC	DFS	Tertile	All	0.266	0.523	.013	18	view →
LGG	OS	Tertile	All	0.369	0.533	.016	9	view →
STAD	DFS	Tertile	IV	0.607	0.155	.010	6	view →
KIRP	OS	Tertile	All	0.962	0.647	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

GAPDHP19–COAD (DFS)

Open the COAD breakdown →